RNase P: role of distinct protein cofactors in tRNA substrate recognition and RNA-based catalysis by Sharin, Ela et al.
RNase P: role of distinct protein cofactors in tRNA
substrate recognition and RNA-based catalysis
Ela Sharin, Aleks Schein, Hagit Mann, Yitzhak Ben-Asouli and Nayef Jarrous*
Department of Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
Received January 24, 2005; Revised May 22, 2005; Accepted August 24, 2005
ABSTRACT
The Escherichia coli ribonuclease P (RNase P) has a
proteincomponent,termedC5,whichactsasacofac-
torforthecatalyticM1RNAsubunitthatprocessesthe
50 leader sequence of precursor tRNA. Rpp29, a con-
served protein subunit of human RNase P, can sub-
stitute for C5 protein in reconstitution assays of M1
RNA activity. To better understand the role of the for-
mer protein,we compare the mode of action of Rpp29
to that of the C5 protein in activation of M1 RNA.
Enzyme kinetic analyses reveal that complexes of
M1 RNA–Rpp29 and M1 RNA–C5 exhibit comparable
bindingaffinitiestoprecursortRNAbutdifferentcata-
lytic efficiencies. High concentrations of substrate
impedetheactivityoftheformercomplex.Rpp29itself
exhibits high affinity in substrate binding, which
seems to reduce the catalytic efficiency of the recon-
stituted ribonucleoprotein. Rpp29 has a conserved
C-terminal domain with an Sm-like fold that mediates
interaction with M1 RNA and precursor tRNA and can
activate M1 RNA. The results suggest that distinct
protein folds in two unrelated protein cofactors can
facilitate transition from RNA- to ribonucleoprotein-
based catalysis by RNase P.
INTRODUCTION
Biosynthesis of cellular RNA, e.g. mRNA, rRNA and tRNA,
requires small nuclear and nucleolar ribonucleoproteins, some
of which have a large number of protein subunits (1–4).
While main efforts are being made in elucidating the roles
of the RNA moieties of these catalytic ribonucleoproteins in
biological processes (5–7), the precise functions of their pro-
tein components remain largely unknown. One of these cata-
lytic ribonucleoproteins is ribonuclease P (RNase P), a
ubiquitous tRNA processing endonuclease (8–10). Highly
puriﬁed human nuclear RNase P has a single species of
RNA, H1 RNA, which is associated with at least 10 distinct
protein subunits, Rpp14, Rpp20, Rpp21, Rpp25, Rpp29,
Rpp30, Rpp38, Rpp40, hPop1 and hPop5 (11–16). Reconstitu-
tion of the endonucleolytic activity of human RNase P reveals
that H1 RNA and two conserved protein subunits, Rpp21 and
Rpp29 (13,14), are sufﬁcient for the removal of 50 leader
sequence from precursor tRNA in vitro (17). This ﬁnding
raised the concept that binding and cleavage of precursor
tRNA substrates by eukaryotic RNase P may need a few pro-
tein components. Reconstitution systems developed for active
archaeal RNase P ribonucleoproteins support this concept
(18,19).
The role of the subunit Rpp29 in RNA-based catalysis is
highlighted by the ability of this protein to activate the M1
RNA enzyme of Escherichia coli RNase P at low concentra-
tions of magnesium ions (17). Archaeal/eukaryal Rpp29 pro-
teins are central components in the assembly and function of
RNase P (19–22). Archaeal Rpp29 polypeptides are smaller in
size,whencomparedwiththeir eukaryalcounterpartsandhave
structural features found in bacterial and eukaryal proteins, as
revealed from the determination of their NMR and crystal
structures (19,22–24). A prominent structural feature of
Archaeoglobus fulgidus Rpp29 is a sheet of six antiparallel
b-strands wrapped around a core of conserved hydrophobic
amino acids (19). The Methanothermobacter thermoauto-
trophicus Rpp29 has a b-barrel core and unstructured N-
and C-terminal domains containing highly conserved amino
acid residues (19). The crystal structures of Pyrococcus
horikoshii Rpp29 (Ph1771p) and A.fulgidus Rpp29 reveal
that their b-barrel cores are similar to those of Sm proteins
and their N- and C-termini form ﬂexible helical structures
(22,24). These two archaeal Rpp29 proteins, which are struc-
turally related to the bacterial transcription factors Hfq and
NusG, as well as to the eukaryal Sm RNA-binding proteins,
show similarity to the C-terminal domain of human Rpp29
(22,24).
The comparison of the mode of action of Rpp29 to that of
the C5 protein in activation of M1 RNA (17,25) may provide
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doi:10.1093/nar/gki828new insights into the role of these cofactors in tRNA substrate
recognition and RNA-based catalysis.The C5 proteinhas been
shown to enhance the catalytic efﬁciency of M1 RNA and
increase substrate versatility (26). Cysteine-substituted
mutants of C5 proteins and Bacillus subtilis RNase P proteins
associated with their corresponding RNA subunits can be
crosslinked to the 50 leader sequence of precursor tRNA
(27–29). These A- and B-type of bacterial RNase P proteins
augmentthemagnesiumionafﬁnityofenzyme-substrateinter-
mediates by correctly positioning the substrate (29). The bac-
terial RNase P protein stabilizes the holoenzyme against
electrostatic repulsion and increases the turnover rate (30),
possibly by favoring contact of the holoenzyme with the sub-
strate over the product (31,32).
The identity among the amino acid sequences of the A- and
B-type proteins of bacterial RNase P is notably low (33,34),
but they share a short stretch of basic sequence, the RNR
motif, a central cleft and a few aromatic amino acid residues
close to their N-termini (35). Nonetheless, both types of pro-
teins can activate the other type of bacterial RNase P RNA
(24,36),aswellasarchaeal RNasePRNA (37).Thus,common
structural features and biochemical properties of these protein
cofactors facilitate RNA-based catalysis (35). However, the
C5 protein and Rpp29 do not share an apparent identity at their
primary amino acid sequences and thus the molecular basis for
the observed activation of M1 RNA by these two cofactors
(17) is unclear.
We here address some properties of Rpp29 in activating
M1 RNA and compare them to those of the C5 protein
known to function in substrate recognition and catalysis.
The results support the idea that activation of M1 RNA
by these two evolutionarily unrelated protein cofactors is
based on the use of distinct protein folds that perform parallel
functions.
MATERIALS AND METHODS
Site-directed mutagenesis of Rpp29
QuickChange  site-directed mutagenesis kit (Stratagene, CA)
was utilizedto introducesubstitutions of amino acids inRpp29
using designed primers and pHTT7K/Rpp29 as template for
PCR (17), following the manufacturer’s instructions. Muta-
tions were veriﬁed by DNA sequencing.
For construction of Rpp29D1-124, two primers, one encom-
passing the codon that corresponds to methionine at position
125 and downstream sequences of Rpp29, and the other cov-
ering the translation stop codon and upstream sequences, were
utilized for PCR using Rpp29 cDNA as a template. The PCR
product was digested with NdeI and BamHI (sites located in
the primers) and subcloned in-frame with the six histidine
residues of pHTT7K, which was digested with Nde I and
BamHI.
Preparation of recombinant Rpp29 proteins
Wild-type and mutant Rpp29 polypeptides were puriﬁed sub-
sequent to their overexpression for 4 h in an E.coli strain BL21
(1). Fractionation of cell extracts revealed that these poly-
peptides were present in the P30 pellet obtained after centri-
fugation at 30000· g. These proteins aggregate and form
inclusion bodies that required to be solubilized in 1· binding
buffer containing 6 M urea before loading onto nickel-charged
His-Bind resin chromatography columns (Novagen). This
step was followed by extensive wash of the column with 50
bed volumes of 1· binding buffer, containing 30–60 mM
imidazole. Bound proteins were eluted with a gradient of
30–500 mM imidazole. Proteins were assayed for activa-
tion of M1 RNA and split into small aliquots and stored
at  80 C.
Puriﬁed Rpp29 proteins were placed in 1 ml dialysis tubes
(GeBAﬂex-tube, 3.5K; Gene Bio-Application, Israel) and
subjected to sequential dialysis in 2 l volume of DA buffers
(50 mM Tris–HCl, pH 8.0, 50 mM NaCl, 0.05% IGEPAL and
1 mM MgCl2) that contained 4 M urea, 2 M urea and then
without urea. This step was followed by ultracentrifugation of
the protein at 100000· g in a Beckman TLA-55 rotor at 4 C
for 2 h. Protein aggregation was observed at the bottom of the
tube and therefore aliquots of Rpp29 from the upper phase
were collected and stored at  80 C. For gel ﬁltration column
(see below) the Rpp29 protein was sequentially dialyzed as
described above but in 1· PA150 buffer (50 mM Tris–HCl, pH
7.5, 0.1 M NH4Cl, 1 mM MgCl2 and 150 mM NaCl).
Preparation of RNA and determination of
50 end group of tRNA
A plasmid that harbors the Schizosaccharomyces pombe
precursor tRNA
Ser (CUA), pSupS1, which lacks 30 CCA
sequence, was linearized by Taq I and transcription was
done with SP6 RNA polymerase (Promega) in the presence
of 80 mCi of [a-
32P]UTP. After DNase I treatment, Urea Dye
(xylene cyanol 0.005%; bromphenol blue 0.005% and 9 M
urea) and 1–2 ml of phenol were added. The reaction products
were separated in 8% polyacrylamide gel/7 M urea and the
110 nt labeled pSupS1 was excised from the gel, extracted and
ethanol precipitated. Radioactivity (in counts per minute) was
determined by Bioscan QC 2000 beta-counter. The speciﬁc
activity of pSupS1 was  3 · 10
6 c.p.m. per 1 mg of RNA.
For preparation of mature tRNA,
32P-labeled pSupS1 or
E.coli precursor tRNA
TyrSu3, was ﬁrst processed by M1
RNA and then the tRNA product was gel puriﬁed.
The plasmid pJA2 carrying the gene encoding M1 RNA was
linearized by Fok I and RNA was transcribed in vitro by using
T7 RNA polymerase in 100 mltotal volumefor 5h. After DNA
digestion with 1 U of DNase I, RNA was passed twice through
G-50 spin columns prewashed with 1· TS buffer (10 mM
Tris–HCl, pH 7.8, and 100 mM NaCl). For labeling of M1
RNA, 80 mCi of [a-
32P]UTP was added to the transcription
reaction and the 377 nt M1 RNA was gel extracted as
described above for precursor tRNA.
Determination of 50 end group of tRNA, generated from
processing of [a-
32P]ATP-labeled pSupS1 by 2D thin layer
chromatography has been described previously (17).
Reconstitution assays of M1 RNA with Rpp29
M1 RNA was incubated with wild-type or mutant Rpp29
protein in 39 mlo f1 · RP buffer (17), which is a mixture
of 1· MRP buffer (20 mM Tris–HCl, pH 7.5, 10 mM
MgCl2,4 0m MK C l ,2 0mg/ml BSA, 0.2 U of rRNasin,
1 mM DTT and 1 mg of poly I:C RNA) and 1· TNET
buffer (20 mM Tris–HCl, pH 7.5, 35 mM NaCl, 0.1 mM
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b-mercaptoethanol), each added separately to the reaction.
After preincubation for 5–10 min on ice, labeled precursor
tRNA was added and the cleavage reaction proceeded for
the indicated time points at 37 C. Cleavage products were
separated in 8% polyacrylamide/7 M urea gel or 12%
sequencing gel. Bands were visualized by autoradiography
and quantiﬁed by using Scion Image software.
Determination of kinetic parameters
For the determination of Vmax and Km, M1 RNA was incuba-
ted in 1· RP buffer with recombinant C5 protein, Rpp29 or
mutant Rpp29 in molar concentrations indicated in each
experiment. After 5 min incubation on ice, various substrate
concentrations, made of mixtures of unlabeled precursor
tRNA and 0.07 pmol labeled precursor tRNA, were added
to the reconstituted complexes for 5–10 min on ice in 100–
150 ml total volumes. Cleavage reactions proceeded at 37 C
for the indicated time points, at which small aliquots of 10 ml
each were withdrawn and mixed immediately with 10 mlo f
Urea dye. Cleavage products were separated in denaturing
8% polyacrylamide gels and substrate and products were
quantiﬁed by using Scion Image software. Michaelis–
Menten and Lineweaver–Burk plots and calculated para-
meters were according to Sigma Plots and GraphPad Prizm
4 software (17).
Electrophoretic mobility shift analysis
A
32P-labeled precursor tRNA (10000 c.p.m.; 0.07 pmol) and
excess amount (0.5–1 mg) of poly(I:C) RNA were incubated in
100 ml total volumes with wild-type or mutant Rpp29 protein
in 2· TNET buffer for 30 min on ice. In some experiments
incubation was in 1· MK buffer (10 mM Tris–HCl, pH 7.5,
150 mM KCl, 2mM MgCl2and5%glycerol) for 15 min on ice
and then for 10 min at room temperature. In binding assays
with labeled M1 RNA, 500–1000 c.p.m. of internally labeled
M1 RNA transcript was used in 100 ml total volumes. Protein–
RNA complexes were separated in native 4% polyacrylamide
gels (40:0.5 of acrylamide/bis). Because of the low resolution
capacity of native gels, complexes obtained in the presence
of mature tRNA or precursor tRNA were retarded to close
positions. Bands were visualized by autoradiography and
quantiﬁed.
Northwestern blot analysis
Equal amounts (20 pmol) of puriﬁed proteins were separated
in 12% SDS–PAGE, transferred to nitrocellulose membrane
(Schleicher & Schuell) and stained with Ponceau red dye
(Sigma). The membrane was washed in 2· TNET buffer con-
taining 100–200 mM NaCl and 0.2% BSA for 1 h, and then
hybridized with 1 · 10
6 c.p.m.of
32P-labeled precursor tRNA,
M1 RNA or RNase MRP RNA in 2· TNET buffer without
BSA. After 1 h incubation at room temperature with constant
shaking, the membrane was washed three times in 2· TNET
buffers that contained 100–200 mM NaCl, rinsed brieﬂy with
water and exposed to X-ray ﬁlm. As described in some experi-
ments, the membrane was ﬁrst blocked with an excess amount
(5 mg) of unlabeled M1 RNA or precursor tRNA before pro-
ceeding to the hybridization step.
Oligonucleotide binding interference assays
Antisense deoxyoligonucleotides were allowed to anneal
to labeled pSupS1 (0.07 pmol) in 1· BB buffer (10 mM
Tris–HCl, pH 7.5, 150 mM KCl, 1 mM DTT, 2 mM MgCl2
and 5% glycerol) containing 1–3 mg of poly(I:C) RNA. After
annealing for 10 min on ice, 20 pmol of Rpp29 were added for
a4 0ml ﬁnal volume and binding was performed for 10 min on
ice and 10 min at room temperature. Complexes were resolved
in non-denaturing 4% polyacrylamide gel. Substrate and
products were quantiﬁed by using Scion Image software.
UV-crosslinking of Rpp29 to precursor tRNA
A
32P-labeled pSupS1 or its mature tRNA form (without 50
leader sequence) was incubated with recombinant Rpp29 pro-
tein in 1· TNET buffer containing 2 mM MgCl2 for 30 min on
ice. Samples (in total volume of 100 ml) were left untreated or
subjected to UV irradiation (UV light at 254 nm) for 90 s using
Hoefer UVC500 crosslinker. An excess amount (up to 1000-
fold) of cold pSupS1 or mature tRNA transcripts was then
added as speciﬁed. After 10 min at room temperature, samples
wereresolvedinnative 4%polyacrylamidegelandbandswere
visualized by autoradiography.
RESULTS
Wild-type and mutant Rpp29 proteins alter the
cleavage specificity of M1 RNA
M1 RNA cleaves the S.pombe precursor tRNA
Ser (CUA),
pSupS1, between positions A27 and G28 (17). This mis-
cleavage by M1 RNA can be corrected in the presence of
its protein cofactor C5, so that the reconstituted holoenzyme
cleaves between positions G28 and G29 (17). We examined if
the cleavage speciﬁcity of M1 RNA can be corrected by
recombinant Rpp29 and two deletion mutants, Rpp29D194-
220 and Rpp29D162-220, which lack the last 27 and 59 amino
acid residues, respectively (17). The four protein cofactors
tested in the presence of M1 RNA were all able to adjust
cleavage at position G28, thus releasing larger 50 leader
sequences from pSupS1 (Figure 1A, arrows). This 1 nt change
in the cleavage position has been conﬁrmed by analysis of
cleavage products of pSupS1 in an 8% sequencing gel
(Figure 1B). M1 RNA alone was inactive at 10 mM MgCl2
(Figure 1B, lane 3).
The 2D thin layer chromatography revealed pGp as the 50
end group of tRNA products generated in cleavage reactions
of pSupS1 by M1 RNA (Figure 1C, left panel) or M1 RNA-
Rpp29 (Figure 1C, right panel).
The results described above demonstrate that Rpp29 directs
M1 RNA to accurately recognize its substrate and hydrolyze
the phosphodiester bond.
Some kinetic parameters of substrate cleavage by
M1 RNA reconstituted by various protein cofactors
We determined the time course of cleavage of 0.07 mMo f
pSupS1 by 0.025 mM of M1 RNA reconstituted with 0.25 mM
of C5 protein or with 0.25 mM of wild-type or mutant Rpp29
proteins (Figure 2). M1 RNA–C5 cleaved  50% of the
substrate within 16 min (Figure 2A and C), while M1
RNA–Rpp29 processed <30% of the substrate after  1ho f
5122 Nucleic Acids Research, 2005, Vol. 33, No. 16incubation (Figure 2B and C). M1 RNA reconstituted by
Rpp29D194-220 or Rpp29D162-220 was less effective than
M1 RNA–Rpp29 in processing of pSupS1 (Figure 2A–C).
Based on the above results, additional multiple turnover
reactions were carried in the presence of a range of pSupS1
concentration and Lineweaver–Burk plots were prepared
for M1 RNA–C5 (Figure 2D), M1 RNA–Rpp29 (Figure 2E)
and M1 RNA–Rpp29D194-220 (Figure 2F) (Materials and
Methods). In the case of M1 RNA–C5 and M1 RNA–
Rpp29, the dependence of the reaction rates on substrate
concentrations exhibited saturation kinetics, and therefore
the results were ﬁt to Michaelis–Menten equation, produc-
ing values for the kinetic parameters kcat, Km and kcat/Km
(Table 1).
M1 RNA–C5 had a Km value of 0.2 mM, which was  2-fold
lower than the Km value obtained for M1 RNA–Rpp29 or M1
RNA–Rpp29D194-220 (Table 1). Similar Km values were
reported for other prokaryotic precursor tRNAs cleaved by
M1 RNA–C5 and under different reconstitution conditions
(25). The turnover rate, kcat, obtained for M1 RNA–Rpp29
was 5.2 min
 1, while the kcat for M1 RNA–C5 was
18 min
 1 (Table 1). Based on kcat and kcat/Km values,
Rpp29 was less effective by several folds than the C5 protein
in activation of M1 RNA (Table 1). Nonetheless, the turnover
rate and catalytic efﬁciency calculated for M1 RNA–Rpp29
imply that this complex is a genuine catalytic ribonucleo-
protein.
Rpp29D194-220 was less effective than Rpp29 in activation
of M1 RNA with a kcat value of 3.4 min
 1 (Table 1).
Rpp29D162-220 was defective in activation of M1 RNA
and the calculated Vmax of the cleavage reaction was notably
low (Table 1). Therefore, valid Km or kcat values could not
be obtained for this latter mutant protein (Table 1). These
kinetic parameters suggest that the region spanning amino
acids 162–194 in Rpp29 is critical for its function as a protein
cofactor (see below).
We performed additional reconstitution assays but this time
inthe presence ofsubstrateconcentrations thatwereabove and
below the Km values obtained as above. Thus, time course
assays were perform with 0.05–1 mMo fp SupS1, while the
Figure1.CleavagespecificityofM1RNAreconstitutedbyvariousproteincofactors.(A)M1RNA(0.7pmol)wastestedforprocessingofpSupS1(S)in1·RPbuffer
(pH7.5)containing10mMMgCl2intheabsence(lane2)orpresenceof7pmolofC5protein(lanes4and8)or7pmolofwild-typeRpp29(lane5),Rpp29D194-220
(lane6)orRpp29D162-220(lane7)(MaterialsandMethods).Thecleavagereactionsproceededfor2hat37 C.Aspositivecontrol,M1RNAalonewastestedin1·
RPbuffercontaining40mMMgCl2(lane3).Therecombinantproteinsaloneshownoactivity(lanes9–11).Thecleavageproducts,tRNA(30)and50 leadersequence
(50),wereresolvedin8%polyacrylamide/7Mureagel.ArrowspointtothecleavagesitesatpositionsA27andG28(17).(B)ProcessingofpSupS1byM1RNAalone
(lanes3)orbyM1RNAreconstitutedwithRpp29D194-220(lane4),Rpp29D162-220(lane5),Rpp29(lane6)orC5protein(lane7).Theconditionsofthecleavage
reactions were as described in (A) but the cleavage products were separated in an 8% sequencing gel. M1 RNA activated by 80 mM MgCl2 primarily cleaved at
positionA27(lanes2and11),whileM1RNAreconstitutedwiththevariousproteincofactorscleavedatpositionG28.RNAladderswereobtainedbypartialdigestion
ofpSupS1byRNaseT2(lanes8and9).ArrowspointtothetwocleavagesitesatA27andG28.SomeRNAdegradation(lane1)isseeninthegelfront.(C)The2Dthin
layer chromatography of tRNA products of cleavage reactions of pSupS1 by M1 RNA (left panel) and M1 RNA–Rpp29 (right panel). Gp, Ap, Cp, Up and pGp are
shown. Arrows point to the first and second dimension of the chromatography.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5123concentrations of the M1 RNA and protein cofactor were 0.01
and 0.1 mM, respectively (Figure 3A). The activity of M1
RNA–Rpp29 was inhibited at substrate concentrations of
0.5 and 1 mM (Figure 3A, lanes 9–15 and Figure 3C). In
contrast, the activity of M1 RNA–C5 was not noticeably affec-
ted by this range of concentrations of pSupS1 (Figure3B, lanes
7–17 and Figure 3D).
The observations described above reveal a difference
between Rpp29 and the C5 protein, where high concentrations
of pSupS1 impede the activity of M1 RNA reconstituted by the
former protein.Weassumedthatthisdifference mayberelated
to substrate binding properties of these two protein cofactors
(see below).
Substrate binding properties of wild-type and
mutant Rpp29 proteins
It has been reported that type A and B of bacterial RNase P
proteins bind to precursor tRNA (28,29). We thus examined if
Rpp29 can bind to precursor tRNA in vitro. Thus, gel shift
analysis in 2· TNET buffer was performed with labeled
pSupS1 and increasing concentrations of dialyzed
(Figures 4A) or denatured (Figure 4B) Rpp29 proteins. A
retarded complex (C) was seen in the presence of Rpp29
and its formation responded in a dose dependent manner to
Rpp29 (Figure 4A and B). Dialyzed and denatured Rpp29
proteins exhibited relatively high afﬁnity in binding to
Figure 2. Kinetic analysis of substrate cleavage by M1 RNA reconstituted by various protein cofactors. (A) Time course of cleavage of 0.07 mMo fp SupS1 by
0.025 mM of M1 RNA reconstituted with 0.25 mM of Rpp29D194-220 or 0.25 mM of C5 protein. Reaction volumes were 150 ml and incubation was at 37 C. Small
aliquotsof10mleachwerewithdrawnatthefollowingtimepoints:0,2,4,8,16,32and64minandmixedimmediatelywith10mlofUreadye.Analiquotwithdrawn
immediately after addition of substrate to the processing reactions is considered zero time point. Cleavage products, tRNA (30) and 50 leader sequence (50), were
resolvedin8%polyacrylamide/7Mureagel.(B)TimecourseofcleavageofpSupS1asin(A)but0.25mMofrecombinantRpp29andRpp29D162-220wereusedin
thereconstitutionassayswithM1RNA.(C)Graphicrepresentationofthetimecourseofsubstratecleavageseenin(AandB).Substratecleavagemayvaryby<10%.
(D–F) Lineweaver–Burk plots obtained for substrate cleavage by M1 RNA reconstituted with C5 protein, Rpp29 or Rpp29D194-220 as indicated. Calculated
Vmax and Km values are shown (Materials and Methods). Cleavage reactions were performed as described in (A) but increasing concentrations of unlabeled pSupS1
(0.025–0.125 mM) were tested.
Table 1. Kinetic parameters of pSupS1 cleavage by M1 RNA reconstituted by various protein cofactors
M1 RNA
C5 Rpp29 Rpp29D194-220 Rpp29D162-220 Rpp29D1-124
Vmax (pmol min
 1) 0.3 0.1 0.06 0.001 0.08
Km (mM) 0.2 0.41 0.46 — 0.22
kcat (min
 1) 18 5.2 3.4 — 0.41
kcat/Km (min
 1 mM
 1) 90 12.7 7.4 — 1.86
Assay conditions were as described in Materials and Methods. Dialyzed Rpp29 produces a Km value that is different from that reported for denatured Rpp29
used in reconstitution assays with M1 RNA (17). The data represent at least three independent determinations and the kinetic values exhibited a variation
of <10%.
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ively (Figure 4A and B). In contrast, C5 protein did not form a
stable complex with pSupS1 (Figure 4A and B, lane 9). In
effect, the C5 protein did not exhibit non-speciﬁc interaction
with RNA (38) under the binding conditions tested. Competi-
tion assays with unlabeled pSupS1 abolished complex forma-
tion by Rpp29 (data not shown).
Rpp29D194-220 weakly bound to the substrate, when com-
paredwith wild-type Rpp29 (Figure 4C, lanes6–9 versus 2–5),
while no complex was formed in the presence of Rpp29D162-
220 (Figure 4C, lanes 10–13).
Binding of Rpp29 to precursor tRNA was further corrob-
orated by northwestern blot analysis using labeled pSupS1 in a
hybridization buffer that contained 200 mM NaCl (Figure 4E;
Materials and Methods). Rpp29 bound to the substrate
(Figure 4E, lane 3), while Rpp20 and Rpp30 failed to do so
(Figure 4E, lanes 2 and 6), even though equal amounts of
proteins were analyzed (Figure 4D). However, in contrast
to the results of the gel shift assays, Rpp29D194-220 and
Rpp29D162-220 also produced binding signals (Figure 4E,
lanes 4 and 5, respectively). Therefore, we ﬁrst blocked the
membrane with cold M1 RNA and then rehybridized the
washed membrane with labeled pSupS1 (Figure 4F).
Rpp29D162-220 showed very faint, if any, binding signal
(Figure 4F, lane 5), a result that was consistent with the gel
shift assays, in which this truncated protein failed to interact
with the substrate in solution (Figure 4C, lanes 10–13). Since
this analysis is qualitative, no difference was observed in the
binding signals produced by Rpp29 versus Rpp29D194-220
(Figure 4F, lane 3 versus 4).
The above ﬁndings reveal that Rpp29 interacts with pre-
cursor tRNA in the absence or presence of M1 RNA. Of note,
high concentrations of Mg
2+ ions (>10 mM) reduce the cap-
ability of Rpp29 to bind to precursor tRNA (E. Sharin and N.
Jarrous, data not shown).
Rpp29 recognizes the 50 leader sequence of
precursor tRNA
The ability of Rpp29 tobind to pSupS1 or its mature tRNA that
lacks 50 leader sequence was analyzed simultaneously by gel
shift assays under conditions of 1· MK buffer (Figure 5;
Figure 3. High substrate concentrations impede the activity of M1 RNA–Rpp29. (A) M1 RNA (0.01 mM) reconstituted with Rpp29 (0.1 mM) was tested for
processingofpSupS1atconcentrationsrangingfrom0.05to1mM(MaterialsandMethods).Substrate(0.07pmol)was
32P-labeledpSupS1andtheremainingwasgel-
purified, cold pSupS1 RNA transcripts. Cleavage reactions (100 ml volume) proceeded at 37 C and small aliquots were withdrawn at the indicated time points (in
minutes). Samples were resolved in denaturing 8% polyacrylamide gels. As controls, M1 RNA alone was tested in 1· RP buffer containing 10 and 80 mM MgCl2
(lanes 2 and 3, respectively). The positionsof pSupS1 (S), tRNA and 50 leader sequence are indicated.The shorter 50 leader sequence indicatedby an arrow resulted
from incorrect substrate cleavage. (B) Cleavage reactions similar to those shown in (A) were performed with 0.01 mM of M1 RNA and 0.1 mM of recombinant C5
protein.Substrateconcentrationsandtimepointsinminutesareindicated.(C)Graphicrepresentationofthetimecourseofsubstratecleavageseenin(A).Percentage
of cleavage of substrate at various concentrations is expressed as a function of time. Substrate cleavage may vary by <10%. (D) Graphic representation of the time
courseofsubstratecleavagesseenin(B).Percentageofcleavageofsubstrateatvariousconcentrationsisexpressedasafunctionoftime.Substratecleavagemayvary
by <10%.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5125Materials and Methods). Rpp29 and pSupS1 formed two major
complexes, C1 and C2 (Figure 5A, lane 4) while a larger
complex, C3, was seen in longer exposures of this gel (data
not shown). In the presence of mature tRNA, no C2 complex
was seen and formation of the C1 complex was reduced
(Figure 5A, lane 10 versus lane 4). The subunit Rpp21,
which has been shown to interact with precursor tRNA
(14), bound both to precursor and mature tRNA species
(Figure 5A, lane 2 versus lane 8). Neither the subunit
Rpp20 nor Rpp40 formed any complex with pSupS1
(Figure 5A, lanes 5 and 6) or its mature tRNA form
(Figure 5A, lanes 11 and 12). Similar complexes have been
obtained when E.coli precursor tRNA
Tyr and its mature tRNA
form were examined (data not shown).
The interaction of Rpp29 with pSupS1 was further
investigated by oligonucleotide binding interference
assays. Short deoxyoligonucleotides complementary to the
50 leader sequence (50O), the D stem–loop (DO), the anticodon
stem–loop (ACO) and the T stem–loop and acceptor stem
(TO) (Figure 5C) were allowed to anneal to pSupS1
(Figure 5B, lanes 2–6; and data not shown) before addition
of Rpp29 to the binding reaction (Figure 5B, lanes 8–12).
The 50O and DO oligonucleotides inhibited the formation
of the complex between Rpp29 and the substrate (Figure 5B,
Figure 4. Binding of wild-type and mutant Rpp29 proteins to precursor tRNA. (A) Gel shift analysis of binding of Rpp29 to precursor tRNA. Increasing
concentrations (0.2–2.2 mM) of dialyzed Rpp29 (lanes 2–8) or 0.8 mM of C5 protein were incubated with 2.66 nM of pSupS1 in 100 mlo f2 · TNET buffer
for30minonice(MaterialsandMethods).Sampleswereresolvedinnative4%polyacrylamidegel.Thegelwasdriedandbandswerevisualizedbyautoradiography.
Positionofcomplex(C)isshown.(B)GelshiftassaysusingincreasingconcentrationsofdenaturedRpp29(MaterialsandMethods).Forcomparison,dialyzedRpp29
(0.8mM;lane10)andC5protein(0.5mM;lane9)weretestedunderthesamebindingconditions.(C)Electrophoretic mobility shiftanalysisofbindingofwild-type
and mutant Rpp29 polypeptides to pSupS1. The indicated concentrations (in mM) of denatured Rpp29 (lanes 2–5), Rpp29D194-220 (lanes 6–9), Rpp29D162-220
(lanes 10–13) or dialyzed Rpp29 (lanes 14 and 15) were incubated with 2.66 nM of labeled pSupS1 in 2· TNET buffer (Materials and Methods). The 30 ml samples
were resolved in native 4% polyacrylamide gel (40:0.5 acrylamide/bis) that was dried and bands were visualized by autoradiography. (D–F) Northwestern blot
analysis of binding of wild-type and mutant Rpp29 polypeptides to pSupS1. The indicated proteins (20 pmol each) were separated in 12% SDS–PAGE and then
transferredontonitrocellulosemembranethatwassubsequentlystainedwithPonceaured(D)(MaterialsandMethods).Themembranewashybridizeddirectlywith
32P-labeled pSupS1 (1· 10
6 c.p.m.) (E) or first pre-hybridized with unlabeled M1 RNA (5 mg) (F) and then hybridized with labeled pSupS1 (1 · 10
6 c.p.m.). Bands
were visualized by autoradiography. Protein size markers in kDa are shown.
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oligonucleotides had no effect (Figure 5B, lanes 11 and 12).
Dose response experiments revealed that binding of
Rpp29 to the substrate was more sensitive to the inhibit-
ory effect of the 50O oligonucleotide than that of the DO
oligonucleotide (Figure 5D). Thus, Rpp29 recognizes the
50 leader sequence and may contact the DO of the pre-
cursor tRNA.
The above conclusion is supported by UV-crosslinking ana-
lysis in which we showed that recombinant Rpp29 protein
could be crosslinked efﬁciently to pSupS1 (Figure 5E, lanes
1–7) but not to its mature tRNA form (Figure 5E, lanes 8–14),
suggesting that the substrate rather than the product is prim-
arily recognized by Rpp29.
Rpp29 directly binds to M1 RNA
The impaired activity of M1 RNA observed in the presence of
the truncated mutants of Rpp29, when compared with the
wild-type protein, could also be due to lack of interaction
of these mutants with M1 RNA. To examine this possibility,
northwestern blot analysis was performed using full length,
32P-labeled M1 RNA as a probe (Figure 6A). Rpp29 produced
a binding signal with M1 RNA (Figure 6A, lane 4), while the
subunits Rpp20, Rpp21 and Rpp30 failed to interact with this
RNA (Figure 6A, lanes 1–3 and 7) or activate it (data not
shown). Rpp29D194-220 and Rpp29D162-220 also produced
binding signals with M1 RNA (Figure 6A, lanes 5 and 6).
Similar results were obtained when a similar analysis was
Figure5.BindingofRpp29toprecursorandmaturetRNA.(A)LabeledpSupS1oritstRNAthatlacksthe50 leadersequencewereincubatedwithrecombinantRpp21
(lanes 2 and 8), Rpp21i(lanes 3 and 9), Rpp29 (lanes 4 and 10), Rpp20 (lanes5 and 11)or Rpp40 (lanes 6 and 12) in 1· MK buffer (Materialsand Methods). RNA–
proteincomplexes,C1,C2andC3wereresolvedinnative5%polyacrylamidegel.TheuseofprecursortRNA(lane1)ormaturetRNA(lane7)madenodifferencein
the electrophoretic mobility of the complexes. (B) Labeled pSupS1 substrates (0.03 pmol; lanes 1 and 7) were annealed with 100 pmol of 50O (lanes 2 and 9), DO
(lanes3and10),ACO(lanes4and11)orTO(lanes6and12)oligonucleotideinatotalvolumeof40mlcontaining1·BBbuffer(MaterialsandMethods).Inlane5,
200 pmol of ACO oligonucleotide were included. Denatured Rpp29 (3 mM) (lanes 8–12) was added and complex formation was analyzed by gel shift assays as
described in (A). The two parts of this panel were derived from the same film exposure. (C) Schematic representation of pSupS1 with the 50O, DO, ACO and TO
oligonucleotidesusedinthisstudy.CleavagesiteofM1RNA–Rpp29isindicatedbyanarrow.(D)Percentageofbindinginterferenceasafunctionoftheamountof
50OandDOoligonucleotides.Increasingamountsof50OorDOoligonucleotides(0,0.5,1,5and10pmol)wereincubatedwithpSupS1forannealingbeforegelshift
assayswereperformedinthepresenceofdenaturedRpp29asdescribedin(C).(E)
32P-labeledpSupS1(lane1)ormaturetRNAform(lane8)(4.5nM)wasincubated
with the indicated concentrations of recombinant Rpp29 (lanes 2–6 and lanes 9–13, respectively) in 1 · TNET buffer containing 2 mM MgCl2. Samples were
subjectedtoUV-crosslinking(atUVlightof254nm)for90s(lanes4–7andlanes11–14)orwereleftuntreated(lanes1–3andlanes8–10).Exceptforlanes2and9,
excessamount(4.5mM)ofcoldpSupS1(lanes3–7)ormaturetRNA(lanes10–14)wasaddedasspecificcompetitors.After10minat37 C,allsampleswereresolved
in native 4% polyacrylamide gel and bands were visualized by radiography. An intramolecular crosslink of pSupS1, which migrates slightly faster than the Rpp29–
pSupS1complex(C)isseeninlane7.Higherconcentrations(0.5and1mM)ofRpp29didnotenhancethecrosslinkingsignalunderthesameexperimentalconditions
(data not shown).
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amount of unlabeled pSupS1 before addition of labeled M1
RNA (data not shown). Notably, Rpp21 bound to precursor
tRNA (Figures 5A) but not to M1 RNA (Figure 6A), suggest-
ing that the putative tRNA-binding site in Rpp21 was not used
for non-speciﬁc interaction with M1 RNA. Moreover, when a
32P-labeled RNase MRP RNA was tested as control, both
Rpp29 and Rpp20 produced binding signals (Figure 6B).
Thus, this hybridization method allows the identiﬁcation of
proteins that bind to different RNAs but cannot provide quant-
itative analysis for distinct or similar proteins that bind to the
same RNA.
The ability of Rpp29 to interact with M1 RNA was
examined by gel shift assays. A speciﬁc complex was formed
between M1 RNA and Rpp29 (Figure 6C, lanes 2–6). Rpp29 at
high concentrations formed large complexes with M1 RNA
that remained in the gel wells (Figure 6C, lanes 5 and 6). Of
note, 50% binding of Rpp29 to M1 RNA was seen at >0.8 mM
(Figure6C,lane5),suggestingthatRpp29hasarelatively high
binding afﬁnity to M1 RNA. Nonetheless, this binding afﬁnity
is several magnitude lower than that obtained for binding of
the C5 protein to M1 RNA (Kd ¼ 0.4 nM) (33,38).
The results described above, combined with the enzyme
kinetic data, reveal that Rpp29 exhibits dual RNA binding
capabilities, one for binding to M1 RNA and the other for
interacting with the tRNA substrate.
The C-terminal domain of Rpp29 can activate M1 RNA
To have direct evidence that the C-terminal domain of Rpp29
is responsible for activation of M1 RNA, we constructed a
truncation mutant, Rpp29D1-124, which lacks the ﬁrst 124
amino acids of Rpp29 (Figure 7A; Materials and Methods),
and tested the resulted recombinant protein in reconstitution
assays with M1 RNA. Rpp29D1-124 was able to activate M1
RNA in processing of pSupS1 (Figure 7C), with optimal activ-
ity measured at a molar ratio of 1:40 (Figure 7C). The 2D thin
layer chromatography revealed pGp as the 50 end group of
tRNA products generated in cleavage reactions of pSupS1 by
M1 RNA reconstituted with Rpp29D1-124 (Figure 7B). Time
course analysis of substrate cleavage by M1 RNA reconsti-
tuted by Rpp29D1-124 at molar ratios of 1:20 or 1:40 showed
that this protein was less effective by  7-fold than wild-type
Rpp29 in activation of M1 RNA (Figure 7D), a conclusion
that is also supported by comparing the catalytic efﬁciencies,
kcat/Km,ofthesetwoproteins(Table 1).Rpp29D1-124retained
its capability to bind to precursor tRNA as determined by gel
shift assay (Figure 7F, lanes 2–4).
Conserved amino acid residues in the C-terminal
domain of Rpp29 are critical for M1 RNA activation
Structure comparative analyses of archaeal and eukaryal
Rpp29 proteins reveal that the C-terminal domain of human
Rpp29 may acquire an Sm-like fold (22,24), as also predicted
in Figure 7A. We examined two structural motifs in this poten-
tial Sm-like fold: the conserved KH motif (Lys162 and
His163) proposed to contact the RNase P RNA and the poten-
tial three-way salt bridge, wherein Lys179 is highly conserved
(Figure 7A, asterisks) (22,24). Thus, we substituted Lys162
and His163 with two asparagine residues in Rpp29KH and
replaced Lys179 with asparagine in another mutant,
Rpp29K179N (Materials and Methods). Time course analysis
of substrate cleavage revealed that Rpp29KH served as a weak
cofactor in activation of M1 RNA (Figure 7E). In contrast,
Rpp29K179N stimulated M1 RNA activity more efﬁciently
Figure 6. Binding of Rpp29 to M1 RNA. (A) Northwesternblot analysis of binding of Rpp29 to M1 RNA. The indicated proteins (20 pmol each) were separated in
12%SDS–PAGEandthentransferredontonitrocellulosemembranethatwashybridizedwith1 · 10
6c.p.m.of
32P-labeledM1RNA(MaterialsandMethods).Bands
werevisualizedbyautoradiography.RecombinantproteinsandproteinsizemarkerswerevisualizedbystainingofthemembranewithPonceaured(datanotshown).
(B) Northwestern blot analysis using a
32P-labeled RNase MRP RNA (265 nt) as probe. (C) Gel shift analysis of binding of Rpp29 to M1 RNA. Increasing
concentrationsofdialyzedRpp29(lanes2–8)wereincubatedwith2.6nMofinternally
32P-labeledM1RNAin2·TNETbuffer(MaterialsandMethods).The100ml
sampleswereresolvedinnative4%polyacrylamidegelandtheradioactivebandswerevisualizedbyautoradiography.PositionoftheM1RNA–Rpp29complex(C)
is shown. Complexes of M1 RNA–Rpp29 remainedin the gel wellswhen high concentrations of Rpp29 were used (lanes 5 and 6). Lanes 7 and 8 show inhibitionof
complex formation by unlabeled M1 RNA used as a specific competitor.
5128 Nucleic Acids Research, 2005, Vol. 33, No. 16than Rpp29 (Figure 7E). Rpp29K179N bound to the substrate
less efﬁciently than Rpp29 (Figure 7G, lanes 2–4 versus lanes
5–7) but we found no change in substrate binding capability
of Rpp29KH (data not shown). Comparison of the M1 RNA
binding capabilities of these two mutants revealed that
Rpp29KH did not bind to M1 RNA at 1.2 mM protein con-
centration (Figure 7H, lane 2), while Rpp29K179N shifted the
M1 RNA to large complexes that entered the gel (Figure 7H,
lanes 5–7; arrow).
The above ﬁndings demonstrate that substitution of the KH
motif in Rpp29 affects its interaction with M1 RNA, while
replacing lysine with asparagine at position 179 reduces the
binding afﬁnity of the mutant protein to precursor tRNA and
improves the catalytic efﬁciency of M1 RNA.
DISCUSSION
Properties of the M1 RNA–Rpp29 chimeric
ribonucleoprotein
We have shown that M1 RNA and Rpp29 form a catalytic
ribonucleoprotein that exhibits high binding afﬁnity to tRNA
Figure 7. TheC-terminaldomainofRpp29isresponsibleforactivationofM1RNA.(A)SecondarystructureoftheC-terminaldomainofRpp29aspredictedbythe
PSIPREDProteinStructurePredictionsoftware(39).a-helicesareshownascylinders,b-strandsasarrowsandturnsaslines.Anarrayofsixb-strandsthatmayform
an Sm-like fold spans amino acid residues at positions 125–220 of Rpp29. Sm-like folds of six anti-parallel b-strands exist in archaeal Rpp29 counterparts (22,24).
Bold arrows indicate the starts of the Rpp29D162-220 and Rpp29D194-220 mutants. Asterisks point to amino acids that were substituted in Rpp29KH and
Rpp29K179N. (B) The 2D thin layer chromatography of tRNA products of cleavage reactions of pSupS1 by M1 RNA–Rpp29D1-124. Gp, Ap, Cp, Up and
pGp are shown. Arrows point to the first and second dimension of the chromatography. (C) Increasing concentrations of recombinant Rpp29 and Rpp29D1-124
polypeptides were tested for activation of 0.02 mM of M1 RNA. Cleavage of 0.07 mMo fp SupS1 was for 120 min at 37 C. Substrate and cleavage products were
resolvedin8%polyacrylamide/7Mureagel,bandswerequantifiedandplottedaspercentageofsubstratecleavageperproteinconcentration.Substratecleavagemay
varyby<10%.(D)TimecourseofpSupS1substratecleavagebyM1RNA(0.02mM)reconstitutedwithwild-typeRpp29atamolarratioof1:20orwithRpp29D1-124
atmolarratiosof1:20and1:40.Substrateandcleavageproductswereresolvedin8%polyacrylamide/7Mureagel,bandswerequantifiedandplottedaspercentageof
cleavage per time (in minutes). Substrate cleavage may vary by <10%. (E) Time course of substrate cleavage by M1 RNA (0.02 mM) reconstituted with wild-type
Rpp29, Rpp29KH or Rpp29K179N at molar ratios of 1:20. Substrate cleavage analysis was as in (D). (F) Gel shift analysis that shows binding of pSupS1 by the
indicatedconcentrationsofRpp29D1-124.BindingconditionsandanalysisofcomplexeswereasdescribedinFigure4A.(G)GelshiftanalysisofpSupS1bindingby
wild-type Rpp29 (lanes 2–4) and Rpp29K179N (lanes 5–7) at the indicated concentrations. Binding conditions and analysis of complexes were as described in
Figure 4A. (H) Binding of M1 RNA by the indicated concentrations of Rpp29KH (lanes 2–4) or Rpp29K179N (lanes 5–7). Binding conditions and analysis of
complexes (C) were as described in Figure 4B. Arrow points to large complexes of Rpp29K179N formed with M1 RNA.
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Nonetheless, M1 RNA–Rpp29 is catalytically less effective
than the M1 RNA–C5 complex.
Rpp29 has a role in substrate recognition that is mediated by
itsC-terminaldomain. Thus,Rpp29may augmentthe catalytic
efﬁciency of M1 RNA by facilitating direct interaction with
precursor tRNA.
The heterologous reconstitution of M1 RNA activity with
Rpp29 as described in this study has several new enzymolo-
gical and biological insights. First, heterologous reconstitution
systems developed for bacterial RNase P ribonucleoproteins
(RNPs)have producednovelﬁndingsrelatedtotheimportance
of the structure rather than the primary amino acid sequences
of bacterial protein subunits in holoenzyme function
(24,29,35). The ability of Rpp29 to activate M1 RNA further
emphasizes the dependence of this RNA catalyst on the struc-
ture of its interacting protein. Second, in contrast to the homo-
logous reconstitution system of human mini-RNase P that
involves at least three components, e.g. Rpp21, Rpp29 and
H1 RNA (17), which makes it difﬁcult to elucidate the exact
role and contribution of each subunit in substrate recognition
and catalysis, the simple nature of the heterologous reconstitu-
tion system of M1 RNA and Rpp29 allows the examination of
the role of this protein cofactor in substrate binding and cata-
lysis. Third, M1 RNA is functional in mammalian cells as a
targeting ribozyme in the presence ofexternal guide sequences
(40) and puriﬁed human RNase P protein preparations have
been shown to activate M1 RNA in vitro (40), thus strength-
eningthe biological relevance of ourstudyon activation of M1
RNA by Rpp29.
A major difference between the C5 protein and Rpp29 in
activation of M1 RNA is that the latter protein cofactor can
facilitate multiple turnover reactions of substrate cleavage as
long as substrate concentration is <0.5 mM (Figure 3), a value
that is close to the calculated Km value of M1 RNA–Rpp29
(Table 1). In contrast, M1 RNA–C5 remains active when
substrate concentrations are high, well above the Km value.
Rpp29 itself has a relatively high binding afﬁnity to precursor
tRNA. Our gel shift assays reveal that the C5 protein does not
bind to pSupS1 under conditions that facilitate binding by
Rpp29 (Figure 4). Lack of or weak interaction of the C5
protein alone with precursor tRNA may explain why high
concentrations of substrate do not inhibit the activity of the
holoenzyme. In contrast, C5 protein has been shown to exhibit
a very high binding afﬁnity (Kd ¼ 0.4 nM) to its natural M1
RNA partner (33,38).
Protein folds and RNase P RNA-based catalysis
Rpp29 is conserved in Eucarya and Archaea (19,21) and is
composed of two major domains (41). The most conser-
ved part of Rpp29 corresponds to its C-terminus, while the
N-terminal part of Rpp29, which harbors nuclear/nucleolar
localization domains (42), is preserved among eukaryotic
homologs. The C-terminal domain of Rpp29 promotes direct
interactions with precursor tRNA and M1 RNA. A truncation
mutantofRpp29,Rpp29D1-124,whichhastheC-terminalpart
that possesses an Sm-like fold, is sufﬁcient for substrate bind-
ing and activation of M1 RNA. Such dual RNA-binding cap-
abilities have also been proposed for the C5 protein (35). The
role of Rpp29 and C5 protein in substrate recognition and
catalysis is different from those reported for other protein
cofactors of RNA catalysts, such as the Saccharomyces
cerevisiae CBP2 and Neurospora crassa CYT-18, which
facilitate the tertiary folding of the S.cerevisiae mitochond-
rial bI5 group I intron RNA (43) or the LtrA protein that
stabilizes the catalytically active structure of Lactococcus
lactis Ll.LtrB group II intron (44).
The 3D structures of human Rpp29 and C5 protein are not
available. Nonetheless, the tertiary structures of the RNase P
proteins from B.subtilis, Staphylococcus aureus and Thermo-
toga maritima have been resolved (34,45,46). These bacterial
proteins share a homologous structure that bears several
potential RNA-binding sites, e.g. a central cleft, a metal-
binding loop and an RNR motif (29). The central cleft in
the B.subtilis RNase P protein and the C5 protein probably
mediates interaction with precursor tRNA (27–29). The
predicted secondary structure (39) of the C-terminus of
human Rpp29 reveals an array of six b-strands with a-helices
at both sides typical of an Sm-like fold (Figure 7A) (22,24)
that may interact with RNA (19,22–24,47,48). Of note,
archaeal Sm proteins have been shown to bind to RNase
P RNA (48). Based on our mutational analysis, the KH
motif, which is located in the loop between the b2 and b3
strands in Rpp29 (Figure 7A) (22,24) may contact the
M1 RNA. Based on structural studies, these two amino acid
residues in Rpp29 have been proposed to be involved in
RNase P RNA–protein interaction (22,24). In contrast, sub-
stitution of Lys179, which is found in the loop between the
b4 and b5 strands of Rpp29 (Figure 7A) (24) affects substrate
binding. Lys179 in human Rpp29 corresponds to Lys58 in
the A.fulgidus Rpp29 that is part of a three-way salt bridge
proposed to have a role in protein stability (24). Since sub-
stitution of Lys179 in Rpp29 alters the RNA binding proper-
ties of Rpp29, this conserved residue (19,22,24) may have a
unique role in shaping or stabilizing the global structure of the
protein (24). Work is in progress to examine the effect of
substitution of Lys179 to amino acids other than asparagine
(this polar residue can be part of salt bridges in proteins) on
activation of M1 RNA and human mini-RNase P (E. Sharin
and N. Jarrous, unpublished data). In addition, since Rpp29 is
also a core component of RNase MRP, substitution of Lys179
may also affect RNase MRP function in rRNA processing
(49,50).
The distinct structures of bacterial RNase P proteins and
archaeal/eukaryal Rpp29 suggest that these ancient protein
cofactors belong to unrelated protein families with analogous
functions in RNase P RNA-based catalysis (41). Nonetheless,
these proteins are structurally and genetically linked to ribo-
somal proteins and translation factors (17,22,34,45,46). Thus,
archaeal Rpp29 proteins exhibit topological resemblance to
the bacterial translational regulator Hfq (22,24) and Haloar-
cula marismortui ribosomal protein L21 (22), both of which
possessSm-likefolds(22,24).The proteinsubunitofB.subtilis
RNase P shares common structural features with ribosomal
protein S5 and the ribosomal translocase EF-G (45). Transla-
tion of bacterial RNase P proteins and the ribosomal protein
L34overlapsinbacteria whileRpp29codinggenesareembed-
ded in ribosomal protein operons in archaea (51). The genetic
links and structural resemblance of these highly conserved
basic proteins, probably derived from ancient RNA-binding
peptides (52), suggest that they have emerged and evolved
5130 Nucleic Acids Research, 2005, Vol. 33, No. 16during transition of the ribosome and RNase P from RNA to
RNP enzymes.
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